Related Tags >> Jazz Pharmaceuticals Cypress Bioscience Cymbalta Forest Laboratories

Fibromyalgia News

Most Popular Fibromyalgia Story

FDA approves new fibromyalgia drug

January 15, 2009 — 8:50am ET | By Maureen Martino

The FDA has approved Forest Laboratories and Cypress Bioscience's fibromyalgia drug Savella. Fibromyalgia is a chronic condition characterized by joint and muscle pain and decreased physical Read more...

Fibromyalgia Press Releases

Pierre Fabre Médicament is Granted Authorisation in Australia to Market the Milnacipran JONCIA® to Treat Fibromyalgia
The Fibromyalgia Drug Market Will Experience Minimal Growth over the Next Decade, Increasing from Nearly $1.6 Billion in 2
TONIX Pharmaceuticals Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms an
U.S. Fibromyalgia Patients Currently Taking an Approved Therapy are More Likely to Request a Discontinuation of Their Trea
TONIX Pharmaceuticals to Present at the OneMedForum San Francisco 2011 on January 11 and at the Biotech Showcase™ on Janua

Latest Headlines

Chelsea Therapeutics reports positive efficacy results in PhII fibromyalgia study
December 22, 2011
Jazz shares hit sour note as FDA rejects fibromyalgia drug
October 11, 2010
Jazz fibromyalgia drug nixed by FDA panel
August 23, 2010
Jazz shares hit high note on fibromylagia data
June 15, 2009
FDA approves new fibromyalgia drug
January 15, 2009
Cypress inks $75M deal to acquire Proprius
February 25, 2008
ALSO NOTED: Paion inks $102M deal; Sepracor chairman plans retirement years;and much more...
January 2, 2008
ALSO NOTED: MiddleBrook lines up $10M in financing; Cypress releases positive fibromyalgia data;and much more...
November 8, 2007
Sosei drug fails Phase II, but hope remains
September 18, 2007

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events